Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 41 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Association between postoperative bowel symptoms and social isolation in patients with rectal cancer: the moderating effects of social support and psychological resilience
    Yaolan Wang, Lin Yao, Xinlei Zhao +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  2. Neurologist-focused workflows for immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy and CD3-engaging bispecific antibodies
    Walid Alesefir, Mariam Hejazi, Basil Alashger +6
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  3. Integrated bioinformatics and machine learning identify key hub genes in early-onset gastric cancer
    Shaoxiong Yi, Qiuxia Chen, Jiaxin Wu +8
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  4. Optimizing early identification and management of trastuzumab deruxtecan-related interstitial lung disease: insights from a multidisciplinary expert panel
    Luca Licata, Camilla Lisanti, Grazia Arpino +8
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  5. Epithelial-mesenchymal transition plasticity in breast cancer: regulatory mechanisms and therapeutic implications
    Chunlei Wang, Jie Cao, Bo Qin
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  6. Tumor lysis syndrome in breast cancer: a systematic review of the literature
    Min Zhang, Junli Li, Linhan Zeng +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  7. Practice patterns in myeloma bone disease: a multi-center survey
    Timothy Schmidt, Ryan Gennette, Craig Cole +11
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  8. Peripheral blood mRNA-based prognostic model for progression to metastatic castration-resistant prostate cancer and identification of SLC6A8 as a glycolysis-promoting biomarker
    Sicong Li, Heling Zhou, Yi Wu +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  9. Predicting recurrence risk after neoadjuvant therapy in breast cancer: a single-center retrospective cohort study integrating residual cancer burden and immune microenvironment features
    Zhihua Zhao, Rui Deng, Liangliang Bai +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  10. Identification of SLC15A3 as a shared prognostic biomarker for AML and COVID-19 via integrative bioinformatics, machine learning and Mendelian randomization
    Miaomiao Liu, Junhui Zhu, Huan Li
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  11. Preoperative versus postoperative single-fraction or fractionated stereotactic radiosurgery for resected brain metastases: a systematic review and network meta-analysis
    Tian Zhao, Shan Lu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  12. Predicting the risk of chemotherapy-induced myelosuppression in clinical practice: an interpretable machine learning approach based on routine laboratory data
    Hao Fan, Xuejiao Wu, Zhenyu Cheng +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  13. Survival benefits and prognostic models of surgical resection versus continued medical treatment in CNLC stage IIb/IIIa hepatocellular carcinoma after meeting resectability criteria following conversion therapy
    Jian Qiu, Zhenghui Ye, Liyang Zhao +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  14. Radiotherapy combined with anlotinib for recurrent high-grade soft tissue sarcoma of the scalp: a case report
    Bingxuan Li, Jinling Ren, Xiaoxia Song +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  15. FN1 promotes invasion of RCC via YWHAZ-associated signaling with partial involvement of the PI3K-Akt pathway
    Chao Zhang, Yu Gao, Tao Yang +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  16. Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia
    Ricardo Brugés, Carlos Carvajal, Angela Luna-Meza +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  17. Dynamic changes in serum carcinoembryonic antigen independently predict disease-free
    Jing Xue, Qianqian Men, Xiaofei Tang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  18. Efficacy and safety of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer after EGFR-TKI resistance: a systematic review and meta-analysis
    Yilin Chen, Shuaixuan Chen, Hang Zhang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  19. Acrolein target-linked toxicological perturbation and tumor-immune microenvironment heterogeneity in colorectal cancer
    Gongming Cheng, Liuqun Shan, Wenjie Shi +3
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  20. Hippo signaling-linked circulating microRNA networks are associated with cardiovascular disease in type 2 diabetes.
    Zein Mersini Besharat, Sofia Trocchianesi, Giuseppina Emanuela Grieco +19
    Journal of the Endocrine SocietyPeer-reviewedCC BYFull textOncologyEurope PMC
  21. Host determinants of immune-related adverse events during immune checkpoint inhibition
    Akram Alwithenani
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  22. Extrachromosomal circular DNA drives focal amplification of AGAP2-AS1 to promote cutaneous tumorigenesis
    Jin Zhang, Zeying Liu, Jinzhi Zhao +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  23. Baseline D-Dimer Predicts Subsequent Venous Thromboembolism in 23,505 Patients with One of 11 Solid Malignancies: An 11-Year Retrospective Cohort Study
    Yoshihiro Tanaka, Yuta Sato, Yuji Hatanaka +7
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  24. Comparison of Fludarabine/Treosulfan Conditioning with Melphalan-Based Sequential Conditioning in Patients with MDS and Increased Blasts Undergoing Upfront Transplantation
    Judith Metzdorf, Artur Schneider, Jacob Pyka +7
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  25. Cancer care: incidence, hospitalization and medical rehabilitation statistics for Germany from 2003 to 2016.
    Enno Nowossadeck, Benjamin Barnes
    BMC health services researchPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ